Subramaniam Somu's Form 4 filing
Ventyx Biosciences, Inc. (VTYX) · filed Apr 25, 2023
- Accession no.
- 0000899243-23-011699
- Filed
- Apr 25, 2023
- Trade date
- Apr 21-25, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $3.85M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Subramaniam SomuCIK 0001508910 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 21, 2023 | Common Stock | SSaleDisposed | −8,642 | $37.51F2 | −$324,161.42 | 9,968,403 | Indirect | |
| Apr 24, 2023 | Common Stock | SSaleDisposed | −25,139 | $37.95F8 | −$954,025.05 | 9,943,264 | Indirect | |
| Apr 24, 2023 | Common Stock | SSaleDisposed | −65,426 | $38.90F11 | −$2,545,071.4 | 9,877,838 | Indirect | |
| Apr 25, 2023 | Common Stock | SSaleDisposed | −793 | $38.88 | −$30,831.84 | 9,877,045 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average share price of an aggregate total of 8,642 shares sold in the price range of $37.50 to $37.555. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F8
Represents the weighted average share price of an aggregate total of 25,139 shares sold in the price range of $37.50 to $38.50. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F11
Represents the weighted average share price of an aggregate total of 65,426 shares sold in the price range of $38.5004 to $39.17. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.